Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to Acquire the Company’s Digital Pathology Business
Healthcare IT Today
DECEMBER 27, 2022
Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A Dynamyx technology ownership and ongoing development and engineering will be led in the U.S.
Let's personalize your content